16
Mar
Denmark is facing its “Nokia moment”; drugmaker Novo Nordisk has ballooned into a $100-billion giant, dominating its home stock market just as the Finnish firm did at the height of the 1990s tech boom.
While the mobile phone maker’s market value eventually slumped, there is a reason for thinking that Novo can remain a growth engine for the Danish economy for years to come.
While the mobile phone maker’s market value eventually slumped, there is a reason for thinking that Novo...